These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11336685)

  • 21. Regulatory B cells in autoimmune diseases: how do they work?
    Lemoine S; Morva A; Youinou P; Jamin C
    Ann N Y Acad Sci; 2009 Sep; 1173():260-7. PubMed ID: 19758160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The role of regulatory T cells in the development of autoimmune process in multiple sclerosis].
    Eliseeva DD; Zavalishin IA; Karaulov AV; Bykovskaia SN
    Vestn Ross Akad Med Nauk; 2012; (3):68-74. PubMed ID: 22712278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subsets of CD4+ T cells and their roles in the induction and prevention of autoimmunity.
    Fowell D; McKnight AJ; Powrie F; Dyke R; Mason D
    Immunol Rev; 1991 Oct; 123():37-64. PubMed ID: 1684782
    [No Abstract]   [Full Text] [Related]  

  • 24. A peptide tetramer Tk-tPN induces tolerance of cardiac allografting by conversion of type 1 to type 2 immune responses via the Toll-like receptor 2 signal-promoted activation of the MCP1 gene.
    Li Z; Yang N; Zhou L; Gu P; Wang H; Zhou Y; Zhou P; Lu L; Chou KY
    Immunology; 2016 Mar; 147(3):355-66. PubMed ID: 26694804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation.
    Foussat A; Cottrez F; Brun V; Fournier N; Breittmayer JP; Groux H
    J Immunol; 2003 Nov; 171(10):5018-26. PubMed ID: 14607898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
    Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ
    Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of antibody treatment on regulatory CD4(+)CD25(+) T cells.
    Yi H; Zhang J; Zhao Y
    Transpl Immunol; 2008 Apr; 19(1):37-44. PubMed ID: 18346636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunotherapy with iTreg and nTreg Cells in a Murine Model of Inflammatory Bowel Disease.
    Haribhai D; Chatila TA; Williams CB
    Methods Mol Biol; 2016; 1422():197-211. PubMed ID: 27246035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor beta (TGFβ) plays a crucial role in prolonging allograft survival in an allodepletion ("pruning") skin transplant model.
    Watson D; Zhang GY; Hu M; Wang YM; Fletcher J; Sartor M; Alexander SI
    Transpl Immunol; 2014 May; 30(4):168-77. PubMed ID: 24746800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking costimulatory pathways: prospects for inducing transplantation tolerance.
    Verbinnen B; Van Gool SW; Ceuppens JL
    Immunotherapy; 2010 Jul; 2(4):497-509. PubMed ID: 20636004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of dominant tolerance using monoclonal antibodies.
    Agua-Doce A; Graça L
    Methods Mol Biol; 2007; 380():405-29. PubMed ID: 17876109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
    Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation tolerance induced by regulatory T cells: in vivo mechanisms and sites of action.
    Golshayan D; Wyss JC; Abulker CW; Schaefer SC; Lechler RI; Lehr HA; Pascual M
    Int Immunopharmacol; 2009 Jun; 9(6):683-8. PubMed ID: 19136078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FOXP3+ regulatory T cells: from suppression of rejection to induction of renal allograft tolerance.
    Dummer CD; Carpio VN; Gonçalves LF; Manfro RC; Veronese FV
    Transpl Immunol; 2012 Jan; 26(1):1-10. PubMed ID: 21939765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutting edge: allogeneic CD4+CD25+Foxp3+ T regulatory cells suppress autoimmunity while establishing transplantation tolerance.
    Adeegbe D; Bayer AL; Levy RB; Malek TR
    J Immunol; 2006 Jun; 176(12):7149-53. PubMed ID: 16751356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steady state dendritic cells with forced IDO expression induce skin allograft tolerance by upregulation of regulatory T cells.
    Yu G; Fang M; Gong M; Liu L; Zhong J; Feng W; Xiong P; Wang CY; Gong F
    Transpl Immunol; 2008 Jan; 18(3):208-19. PubMed ID: 18047928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory T cells and tolerance induction.
    Fritzsching E; Kunz P; Maurer B; Pöschl J; Fritzsching B
    Clin Transplant; 2009 Dec; 23 Suppl 21():10-4. PubMed ID: 19930310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of inflammatory bowel disease in immunodeficient mice by depletion of regulatory T cells.
    Read S; Powrie F
    Curr Protoc Immunol; 2001 May; Chapter 15():Unit 15.13. PubMed ID: 18432730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells.
    Nishimura E; Sakihama T; Setoguchi R; Tanaka K; Sakaguchi S
    Int Immunol; 2004 Aug; 16(8):1189-201. PubMed ID: 15237110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The therapeutic potential of regulatory T cells for the treatment of autoimmune disease.
    Bluestone JA; Trotta E; Xu D
    Expert Opin Ther Targets; 2015; 19(8):1091-103. PubMed ID: 25881491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.